Skip to content
Luye UK
  • About us
    • About us
    • Environmental, Social and Governance (ESG)
  • Products
  • Business development
  • Content Hub
    • Webinar & Video Series
    • Media Hub
    • Zeyzelf press release
  • Contact us

Zeyzelf® (rivastigmine)
materials order form

Discover the range of Zeyzelf® materials we have
available for healthcare professionals in the UK.

Thank you for submitting your order.

We have received your request and will be in touch shortly.

UK-COR-35 May 2024

European offices

United Kingdom  |  Germany  |  Switzerland

Luye UK
Luye Pharma Ltd
Surrey Technology Centre
Guildford
Surrey GU2 7YG

Luye Germany
Am Windfeld 35,
83714 Miesbach
Germany

Luye Pharma Switzerland AG
Baeumleingasse 22
4051 Basel
Switzerland

Other links

  • Luye Life Sciences
  • Luye Pharma Europe
  • Luye Pharma Group

UK-COR-24(3) March 2025

This page is intended for an audience in the UK

  • About us
  • Products
  • Business development
  • Media Hub
  • Contact us
  • Policies & Plans
  • Marketing opt-in

Professional access

To access this information you must confirm that you are a healthcare professional.

I am a healthcare professional I am a member of the public

You are leaving the site

You are now leaving the Luye Pharma Ltd website to go to an external website over which Luye Pharma has no control and to which our Privacy Policy does not apply. You are solely responsible for your interactions with that website. Click OK to proceed.

OK Stay on site

You are leaving the site

You are now leaving the Luye Pharma Ltd website to go to an external website over which Luye Pharma has no control and to which our Privacy Policy does not apply. You are solely responsible for your interactions with that website. Click OK to proceed.

OK Stay on site

You are leaving the site

You are now leaving the Luye Pharma Ltd website to go to an external website over which Luye Pharma has no control and to which our Privacy Policy does not apply. You are solely responsible for your interactions with that website. Click OK to proceed.

OK Stay on site
Professional access

To access this information you must confirm that you are a healthcare professional.

I am a UK healthcare professionalI am a member of the UK public

UK-COR-23(1) April 2024

Media access

This page is intended for media, journalists and investors.

Are you a member of the media, a journalist or investor?

YESNO

UK-COR-44 April 2024

Professional access

To access this information you must confirm that you are a healthcare professional.

I am a UK healthcare professionalI am a member of the UK public

UK-COR-23(1) April 2024